Depression Health Center

Font Size
A
A
A

FDA OKs New Antidepressant Pristiq

Pristiq Is a Modified Form of the Antidepressant Effexor XR
By Miranda Hitti
WebMD Health News
Reviewed by Louise Chang, MD

March 3, 2008 -- The FDA has approved Pristiq, a new antidepressant that's a modified version of the antidepressant Effexor XR, for the treatment of major depressive disorder in adults.

Pristiq and Effexor XR are made by Wyeth .

Pristiq, which is taken once daily and isn't approved for pediatric patients, will be available in the second quarter of 2008, Wyeth notes.

Pristiq belongs to a class of drugs called serotonin norepinephrine reuptake inhibitors (SNRIs). According to Wyeth, the FDA approved Pristiq based on four studies in which Pristiq trumped a placebo pill at treating major depressive disorder in adults.

Pristiq has also been studied as a treatment for menopausal hot flashes and night sweats. But so far, the drug has only been approved for depression treatment.

Advertise on Fox News Channel, FOXNews.com and FOX News Radio Jobs at FOX News Channel. Internships at FOX News Channel (now accepting Fall interns).
Terms of use. Privacy Statement. For FOXNews.com comments write to foxnewsonline@foxnews.com; For FOX News Channel comments write to comments@foxnews.com
© Associated Press. All rights reserved.
SMARTMONEY ® © 2006 SmartMoney. SmartMoney is a joint publishing venture of Dow Jones & Company, Inc. and Hearst SM Partnership. All Rights Reserved.
All quotes delayed by 20 minutes. Delayed quotes provided by ComStock.
Historical prices and fundamental data provided by Hemscott, Inc.
Mutual fund data provided by Lipper. Mutual Fund NAVs are as of previous day's close.
Earnings estimates provided by Zacks Investment Research.
Upgrades and downgrades provided by Briefing.com.
This material may not be published, broadcast, rewritten, or redistributed. © 2006 FOX News Network, LLC. All rights reserved. All market data delayed 20 minutes.